Related Articles
Luteolin suppresses lipopolysaccharide‑induced cardiomyocyte hypertrophy and autophagy in vitro
Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway
Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy
Metformin attenuates angiotensin II‑induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway